Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - CASH FROM OPERATIONS
Cash from Operations NVO - Novo Nordisk A/S
109 B
LAST VALUE
40.72%
2 YEAR CAGR
19.54%
5 YEAR CAGR
15.43%
10 YEAR CAGR